Olfactory involvement in aging and Alzheimer's disease: an autopsy study
- PMID: 15851853
- DOI: 10.3233/jad-2005-7208
Olfactory involvement in aging and Alzheimer's disease: an autopsy study
Abstract
Olfactory dysfunction and tau pathology in the olfactory bulb increase with the severity of Alzheimer's disease. We report data of a postmortem study in the aged. 130 autopsy cases (81 female, 49 male, aged 61-102, mean 82.48 +/- 4.35 SD) years, underwent a standardized neuropathological assessment with immunohistochemical study of tau pathology in the olfactory bulb and nerve and of Alzheimer's disease using established criteria including Braak staging. All cases of definite Alzheimer's disease (Braak stages 5 and 6) (n = 40) showed large numbers of neuropil threads and neurofibrillary tangles, with amyloid deposits in 32.5% and neuritic plaques in one single case in the olfactory system. Braak stage 4 (n = 27) was associated with mild to moderate tau pathology in 85.2%, and amyloid plaques in 1.1%, Braak stage 3 (n = 28) with olfactory tau lesions in 37.0% and amyloid deposits in one single case, Braak stages 3 and 4 with olfactory tau lesions in 61.1%. Braak stage 2 (n = 15) showed olfactory tau pathology in 31.2%, whereas Braak stages 0 and 1 (n = 15) were all negative. The olfactory system tau score showed highly significant correlations with neuritic Braak stages in the brain, while both scores showed significant but low correlations with age. These data confirm previous studies demonstrating abundant tau pathology in the olfactory system in all definite Alzheimer's disease cases, in two-thirds of limbic Alzheimer's disease, and in almost one-third of non-demented elderly persons with Braak stage 2. There are strong correlations between tau pathology in the olfactory and limbic systems, both with similar increase in severity. Clinical dementia correlated with both Braak and olfactory system tau scores. Since the involvement of both systems is associated with a high risk of cognitive decline, future studies should validate the sensitivity of olfactory mucosa biopsies in the diagnosis of Alzheimer's disease.
Similar articles
-
Olfactory tau pathology in Alzheimer disease and mild cognitive impairment.Clin Neuropathol. 2006 Nov-Dec;25(6):265-71. Clin Neuropathol. 2006. PMID: 17140156
-
Soluble pre-fibrillar tau and β-amyloid species emerge in early human Alzheimer's disease and track disease progression and cognitive decline.Acta Neuropathol. 2016 Dec;132(6):875-895. doi: 10.1007/s00401-016-1632-3. Epub 2016 Oct 21. Acta Neuropathol. 2016. PMID: 27770234 Free PMC article.
-
Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages.Brain. 2016 May;139(Pt 5):1539-50. doi: 10.1093/brain/aww023. Epub 2016 Mar 2. Brain. 2016. PMID: 26936940
-
Neuropathology of Alzheimer's disease: a critical update.J Neural Transm Suppl. 1998;54:77-95. doi: 10.1007/978-3-7091-7508-8_8. J Neural Transm Suppl. 1998. PMID: 9850917 Review.
-
Clinical Correlates of the PET-based Braak Staging Framework in Alzheimer's Disease.J Prev Alzheimers Dis. 2024;11(2):414-421. doi: 10.14283/jpad.2024.15. J Prev Alzheimers Dis. 2024. PMID: 38374747 Review.
Cited by
-
Potential neural substrates underlying circadian and olfactory disruptions in preclinical Alzheimer's disease.Front Neurosci. 2023 Nov 29;17:1295998. doi: 10.3389/fnins.2023.1295998. eCollection 2023. Front Neurosci. 2023. PMID: 38094003 Free PMC article. Review.
-
Ageing and Olfactory Dysfunction in Trisomy 21: A Systematic Review.Brain Sci. 2021 Jul 20;11(7):952. doi: 10.3390/brainsci11070952. Brain Sci. 2021. PMID: 34356186 Free PMC article. Review.
-
Associations of olfactory function with brain structural and functional outcomes. A systematic review.Ageing Res Rev. 2023 Dec;92:102095. doi: 10.1016/j.arr.2023.102095. Epub 2023 Oct 30. Ageing Res Rev. 2023. PMID: 37913831 Free PMC article.
-
Cerebral Braak stage and amygdala granular fuzzy astrocyte status have independent effects on neuronal 3R-tau and 4R-tau accumulations in the olfactory bulb, respectively, in cases with low to intermediate AD neuropathologic change.Acta Neuropathol. 2025 Apr 26;149(1):36. doi: 10.1007/s00401-025-02875-6. Acta Neuropathol. 2025. PMID: 40285882 Free PMC article. No abstract available.
-
Genetic, Transcriptome, Proteomic, and Epidemiological Evidence for Blood-Brain Barrier Disruption and Polymicrobial Brain Invasion as Determinant Factors in Alzheimer's Disease.J Alzheimers Dis Rep. 2017 Sep 28;1(1):125-157. doi: 10.3233/ADR-170017. J Alzheimers Dis Rep. 2017. PMID: 30480234 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical